Article Text

Download PDFPDF

PTU-035 Single Centre Experience With Endoclot Powder Spray For Upper Gastrointestinal Bleed
  1. M Kasimanickam,
  2. S Vinnamala,
  3. MR Andrew,
  4. C Lim,
  5. M Ahmed
  1. Gastroenterology, Good Hope Hospital, Sutton Coldfield, UK


Introduction Endoclot’ (EPI) and ‘Hemospray’ (Wilson Cook) are haemostatic powders marketed for endoscopic use. The powders desiccate bleeding lesions and promote clotting. They can be used either as an adjunct to conventional haemostatic modalities or as monotherapy.

Aim We report our early experience with Endoclot usage in upper gastrointestinal bleed.

Methods N=12 patients; M7:F5; Median age 75y (63y–92y). All were frail with multiple co-morbidities (Table 1). Endoscopic diagnosis: duodenal ulcer (6), bleeding GI lymphoma (2), gastric ulcer (1), post gastric polyp biopsy bleed (1), GIST (1) and Mallow Weiss tear (1). Endoclot was used as monotherapy in 3/12 and as adjunct in 9/12. All patients had immediate haemostasis and one patient had late re bleed at 120hrs (8%). 1/12 died within 24hr. 6/12 were alive at 30 days.

Abstract PTU-035 Table 1

Conclusion Haemostatic powder spray is a promising new technique, particularly for difficult bleeds in frail patients.

Reference Leahy A, et al., Early clinical experience of endoclot™ in the treatment of acute gastro-intestinal bleeding. Gut 2013;62:A149

Disclosure of Interest None Declared.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.